Google is working on some behind-the-scenes changes that should make Android phones feel faster while also improving battery ...

Researchers have developed a new AI-based method for predicting optical transceiver failures in the computer clusters used for AI training. The new technology could allow operators to anticipate ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...

To truly manage a fleet, we have to stop looking at machines solely from the outside. A fluid analysis program is a critical ...

A new University of Nottingham commercialisation venture, BioSee AI, has launched to address one of industrial biotechnology's most costly and ...

Conservation has long wrestled with a deceptively simple question: not whether to act, but where action will matter most. Forest restoration, protected areas, wildlife corridors, and enforcement ...

An expansive study of ticks in New York and the diseases they carry determined that the prevalence of a lesser-known blood parasite is rising. Scientists were expecting to find plenty of Lyme disease ...

AI-powered host-response test designed to deliver lab-level accuracy from a few drops of capillary blood——Breakthrough Device Designation to streamline ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to ...

The new CFO insider anomaly portfolio is already showing positive outsized returns. Click here to read more about the portfolio.

MeMed, a leader in advanced host-response diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to MeMed BV Flextm, a test ...

This is the largest real-world analysis of mycophenolic acid in pediatric lupus nephritis to date, providing a decision-support system to help balance efficacy and safety.